gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Infections, Pneumococcal

gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide has been researched along with Infections, Pneumococcal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Banniettis, N; Benfield, T; Bickham, K; Churchill, C; Dagan, R; Kaminski, J; Lupinacci, R; McFetridge, R; Mercer, S; Musey, L; Park, J; Rämet, M; Richmond, P; Seppä, I; Valentini, P; Wittke, F	1

Trials

1 trial(s) available for gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Infections, Pneumococcal

Article	Year
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2). Vaccine, 2023, 04-06, Volume: 41, Issue:15 Topics: Antibodies, Bacterial; Haemophilus influenzae type b; Hepatitis B Vaccines; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Infant; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Tetanus; Tetanus Toxoid; Vaccines, Conjugate	2023

Article

Year

Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).

Vaccine, 2023, 04-06, Volume: 41, Issue:15

Topics: Antibodies, Bacterial; Haemophilus influenzae type b; Hepatitis B Vaccines; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Infant; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Tetanus; Tetanus Toxoid; Vaccines, Conjugate

2023